Market Developments in Biosimilars - January 9, 2019

December 19, 2018
San Francisco, CA

Willkie Farr & Gallagher LLP and CRA will host a breakfast panel on Market Developments in Biosimilars Seminar during the J.P. Morgan Conference.

During the 2019 J.P. Morgan Healthcare Conference, Willkie Farr & Gallagher LLP and Charles River Associates will host a complimentary breakfast and panel discussion to discuss recent developments in the rapidly developing biosimilars market. Topics include:

• Patent landscapes
• Regulatory environment
• Legislative developments
• Competitive dynamics
• Pricing and reimbursement

Panelists:

Dr. Cartier Esham - Executive Vice President, Emerging Companies at Biotechnology Innovation Organization (BIO)
Mr. Chester “Chip” Davis, Jr. - President and CEO of the Association for Accessible Medicines (AAM)
Mr. Oliver Rocroi - Senior Director of State Government Relations for the California Life Sciences Association (CLSA)
Dr. Gregory K. Bell - Group Vice President and Life Sciences Practice Leader at Charles River Associates (CRA)
 
Moderator: 

Ms. Heather M. Schneider - Partner at Willkie Farr & Gallagher LLP

Registration & breakfast: 7:30 am PDT

Panel: 8:00 am - 9:00 am PDT

Farallon Restaurant, 450 Post Street, San Francisco, CA 94102

To RSVP for this event, please click here.